Get started
Evofem Biosciences, Inc.Evofem Biosciences, Inc.Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

EVFM chart


Full chart

EVFM upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪993.25 K‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.5980 USD
Net income (FY)
‪52.98 M‬ USD
Revenue (FY)
‪18.22 M‬ USD
Shares float
‪100.33 M‬
Beta (1Y)
−0.66

Employees


Employees (FY)
37
Change (1Y)
0
Revenue / Employee (1Y)
‪492.38 K‬ USD
Net income / Employee (1Y)
‪1.43 M‬ USD

About Evofem Biosciences, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Saundra L. Pelletier
Website
evofem.com
Headquarters
San Diego
Founded
2007
FIGI
BBG007BW54K5
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

EVFM news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EVFM is 0.0100 USD — it has increased by 1.01% in the past 24 hours. Watch Evofem Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Evofem Biosciences, Inc. stocks are traded under the ticker EVFM.
EVFM stock has fallen by −21.51% compared to the previous week, the month change is a −16.67% fall, over the last year Evofem Biosciences, Inc. has showed a −85.71% decrease.
EVFM reached its all-time high on Aug 4, 2015 with the price of 169,277.5127 USD, and its all-time low was 0.0060 USD and was reached on Jul 1, 2024. View more price dynamics on EVFM chart.
See other stocks reaching their highest and lowest prices.
EVFM stock is 25.52% volatile and has beta coefficient of −0.66. Track Evofem Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Evofem Biosciences, Inc. there?
Today Evofem Biosciences, Inc. has the market capitalization of ‪1.00 M‬, it has increased by 0.50% over the last week.
Yes, you can track Evofem Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Evofem Biosciences, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
EVFM net income for the last quarter is ‪−2.37 M‬ USD, while the quarter before that showed ‪1.35 M‬ USD of net income which accounts for −275.06% change. Track more Evofem Biosciences, Inc. financial stats to get the full picture.
No, EVFM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 37.00 employees. See our rating of the largest employees — is Evofem Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Evofem Biosciences, Inc. EBITDA is ‪−9.58 M‬ USD, and current EBITDA margin is −88.19%. See more stats in Evofem Biosciences, Inc. financial statements.
Like other stocks, EVFM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evofem Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evofem Biosciences, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evofem Biosciences, Inc. stock shows the sell signal. See more of Evofem Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.